# Platelet Aggregation Function-Guided De-Escalation Antiplatelet Therapy in Patients With Acute Ischemic Stroke

Study · id `cardio:ct-nct07644234` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07644234](<https://clinicaltrials.gov/study/NCT07644234>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07644234

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 3836 participants.

## Technical summary

Registry record NCT07644234. Randomized; no masking; primary purpose prevention. Start 2026-06 (anticipated); primary completion 2028-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 3836 participants (planned count; ClinicalTrials.gov record NCT07644234, source copy `cardio:ctgov-nct07644234-2026-06-12`, retrieved 2026-10-26)
- Planned start: 2026-06 (anticipated) (ClinicalTrials.gov record NCT07644234, source copy `cardio:ctgov-nct07644234-2026-06-12`, retrieved 2026-10-26)
- Primary completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT07644234, source copy `cardio:ctgov-nct07644234-2026-06-12`, retrieved 2026-10-26)
- Completion: 2029-10 (anticipated) (ClinicalTrials.gov record NCT07644234, source copy `cardio:ctgov-nct07644234-2026-06-12`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07644234, source copy `cardio:ctgov-nct07644234-2026-06-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07644234-2026-06-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Platelet Aggregation Function-Guided De-Escalation Antiplatelet Therapy in Patients With Acute Ischemic Stroke
- Acronym: PATH STROKE D
- Condition: Ischemic Stroke
- Condition: Transient Ischemic Attack
- Intervention (Drug): Clopidogrel
- Intervention (Drug): Aspirin
- Lead sponsor: Sichuan Provincial People's Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Transient ischemic attack (mini-stroke) (`cardio:transient-ischemic-attack`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)
- Registry lists this organization as the lead sponsor: Sichuan Provincial People's Hospital (`cardio:org-sichuan-provincial-people-s-hospital`)

## Provenance

Content hash: 3c79289e70c76aaec854fc2ebd043361877c7cc0a2f4b2af8ec22d23377607e9
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
